Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124

Semaglutide, marketed under the brand name Ozempic, has emerged as a transformative intervention in metabolic health management. The FDA initially approved this glucagon-like peptide-1 (GLP-1) receptor agonist for type 2 diabetes treatment. Nevertheless, clinicians increasingly recognize its significant effects on…